UK MHRA No-Deal Proposal Must Be Carefully Managed, UK Medtech Industry Leader Warns
Executive Summary
Questions still remain related to the recent technical notices and consultations from UK MHRA on the effects of a no-deal Brexit. Association of British Healthtech Industries' Phil Brown offers pointers as interested parties prepare to respond the consultations, which have a November 1 deadline.
You may also be interested in...
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.
First Danish Notified Body Named Under EU's Medical Device Regulation
The EU now has a total of 45 notified bodies under the MDR.